Spectrum of disease in HIV-positive patients presenting to a tertiary care hospital: a retrospective, cross-sectional review in Kumasi, Ghana

Table 3 Univariable analysis of risk of mortality as a function of patient comorbidities and characteristics

	Valid N	Hazard Ratio	95% Confidence Interval		p
	Valid N	Hazard Ratio	Lower	Upper	p
Age (per 5 year increase)	244	1.105	0.999	1.222	.052
Male vs Female	245	1.475	0.963	2.258	.07
Referred to KATH: Yes vs No	189	0.828	0.514	1.333	.44
Reason for Admission (Yes vs No)
Constitutional symptoms	240	0.832	0.512	1.353	.46
Neurological symptoms	239	2.113	1.362	3.279	.001
Pulmonary symptoms	240	0.892	0.566	1.407	.62
Cardiac symptoms	240	0.871	0.433	1.753	.70
Gastrointestinal symptoms	241	0.538	0.301	0.962	.04
Other reason for admission	243	1.576	0.783	3.171	.20
Months since HIV diagnosis (per 1 month increase)	205	1.004	0.998	1.009	.18
New vs Known HIV diagnosis	244	0.866	0.554	1.353	.53
HAART: Yes vs No	237	0.969	0.625	1.502	.89
Prophylaxis Medication: Yes vs No	235	1.146	0.675	1.945	.61
HgB (per 1 unit increase)	230	0.996	0.964	1.029	.81
PLT (per 5 unit increase)	224	1.003	0.996	1.010	.43
Febrile Exam: Yes vs No	232	1.342	0.845	2.132	.21
Clinical Stage (vs Stage 0–2)	244				.12
Stage 3		2.937	0.707	12.191	.14
Stage 4		3.794	0.918	15.680	.07
Final Diagnoses (Yes vs No)
ICSOL	245	1.724	1.084	2.742	.02
ICSOL with CT	56	0.402	0.162	1.000	.0501
CT-suggestive Toxoplasmosis	245	0.553	0.174	1.756	.32
Pulmonary TB	245	1.041	0.670	1.619	.86
Encephalopathy	244	2.133	0.927	4.909	.07
Pneumonia	245	1.787	1.089	2.931	.02
Gastroenteritis	245	1.217	0.586	2.527	.60
Candidiasis	245	0.939	0.536	1.643	.82
Pleural Effusion	245	0.735	0.317	1.701	.47
HTN	245	0.610	0.246	1.511	.29
Anemia	245	1.139	0.744	1.743	.55
HIV-Associated nephropathy	245	1.331	0.487	3.640	.58
Hepatitis B	245	1.175	0.511	2.702	.70
Diarrhea	245	1.001	0.404	2.478	.99

ISSN: 1471-2334